Sean Thompson Named NAVEX President and CEO
Current CEO Bob Conlin transitions to Executive Chairman of the Board PORTLAND, Ore.–(BUSINESS WIRE)–NAVEX, the…
News
Northern Trust Announces Investor Relations Transition
CHICAGO–(BUSINESS WIRE)–Northern Trust today announced that Jennifer Childe has joined Northern Trust as Director of…
Madrona and PitchBook Partner to Bring Machine Intelligence to the Intelligent Applications 40 (#IA40) List
PitchBook Previews a New Machine Learning Intelligent Application that Predicts Company Outcomes and Finds that…
Lenders One® Adds Snapdocs as a Preferred eClosing Provider
Snapdocs offers its digital mortgage closing platform to national alliance network of more than 250…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Okta, Inc. (OKTA) on Behalf of Investors
Shareholders with $100,000 losses or more are encouraged to contact the firm. LOS ANGELES–(BUSINESS WIRE)–Glancy…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Enservco Corporation (ENSV) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Westcon-Comstor reports FY22 financial results
Revenue up 11.8% to US$2 890.4 million following demand for all technologies in the Westcon…
Castellum, Inc. Announces Appointment of Former Congressman Jim Moran to Advisory Board
Castellum, Inc. Announces Appointment of Former Congressman Jim Moran to Advisory Board Castellum, Inc. (OTC:…
AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM”…
SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment
Pre-clinical trials based on the proprietary combination demonstrate significant suppressive effect on alcohol consumption TEL…
Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity
SCOTTSDALE, Ariz., May 24, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”…
Agenus Announces Late-Breaking Oral Presentation at ESMO-GI and Strategies to Advance Botensilimab
Data to be Presented in Heavily Pretreated MSS-CRC Speed and Innovation Core to Development Strategy…
Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
– Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible…
Clearmind Medicine and SciSparc Collaboration Yields Positive Results for its Psychedelic Combination Treatment
Pre-clinical trial based on the proprietary combination demonstrates high safety profile in addition to a…
uniQure Announces FDA Acceptance of Biologics License Application for Etranacogene Dezaparvovec under Priority Review
If approved, etranacogene dezaparvovec would be the first gene therapy option for people living with…
scPharmaceuticals to Present at the Jefferies Healthcare Conference
BURLINGTON, Mass., May 24, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
Genocea Announces Wind Down of Operations and Delisting From NASDAQ
CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
Glen Rock, N.J., May 24, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
Rubius Therapeutics Appoints Noubar Afeyan as Chairman of its Board of Directors
CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
Surrozen Presents Data on Lead Therapeutic Candidates at Digestive Disease Week (DDW)
SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) — Surrozen, Inc. (Nasdaq: SRZN), a…